Sign up for our FREE GI E-Weekly for more coverage like this sent to your inbox!
Dr. Meltzer is studying molecular biomarkers that are able to identify Barrett’s Esophagus and indicate when a patient is likely to develop esophageal cancer.
More Articles on Gastroenterology:
8 Gastroenterology Devices Receive FDA 510(k) Clearance in March
ResearchMoz Releases Endosocpy Market Outlook Report
6 Steps to Keep GI-Driven Surgery Center Patients Safer
